老虎证券

BRIEF-Lilly Exec Says U.S. Zepbound Performance Is Going Very Well

Reuters
2025/02/07
BRIEF-Lilly Exec Says U.S. Zepbound Performance Is Going Very Well

Feb 6 (Reuters) - Eli Lilly and Co LLY.N:

  • LILLY EXEC SAYS UPTAKE OF SINGLE-USE ZEPBOUND VIALS INCREASED IN Q4 THROUGH DIRECT TO CONSUMER WEBSITE SALES - CONF CALL

  • LILLY EXEC SAYS U.S. ZEPBOUND PERFORMANCE IS GOING VERY WELL

  • LILLY EXEC SAYS IN Q4 ZEPBOUND BECAME THE MARKET LEADER IN THE ANTI-OBESITY MARKET AS MEASURED BY NEW PRESCRIPTIONS

  • LILLY EXEC SAYS U.S. PRESCRIPTIONS OF ALZHEIMER'S DRUG KISUNLA STEADILY INCREASING SINCE LAUNCH

  • LILLY EXEC SAYS CO PLANS TO START SEVERAL TRIALS ASSESSING INCRETINS IN AREAS SUCH AS BRAIN HEALTH, SUBSTANCE USE DISORDERS, PAIN, OTHERS

Further company coverage: LLY.N

((Reuters.Briefs@thomsonreuters.com;))

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10